Genexine Inc. 13D/13G Filings for I-Mab (IMAB)

Genexine Inc. 13D and 13G filings for I-Mab:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-06-21
11:10 am
Sale
2021-05-19 13G I-Mab
IMAB
Genexine Inc. 8,488,885
4.970%
-2,083,938decrease
(-19.71%)
Filing
2021-02-16
08:01 am
Purchase
2020-12-31 13G I-Mab
IMAB
Genexine Inc. 10,572,823
6.290%
10,572,823increase
(New Position)
Filing